Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 313

1.

Preventing morbidity and mortality from sickle cell disease. A public health perspective.

Olney RS.

Am J Prev Med. 1999 Feb;16(2):116-21. Review.

PMID:
10343888
3.

Geographic differences in mortality of young children with sickle cell disease in the United States.

Davis H, Gergen PJ, Moore RM Jr.

Public Health Rep. 1997 Jan-Feb;112(1):52-8. Erratum in: Public Health Rep 1997 Mar-Apr;112(2):89.

4.

Sickle cell disease: the need for a public health agenda.

Yusuf HR, Lloyd-Puryear MA, Grant AM, Parker CS, Creary MS, Atrash HK.

Am J Prev Med. 2011 Dec;41(6 Suppl 4):S376-83. doi: 10.1016/j.amepre.2011.09.007.

PMID:
22099361
5.

Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review.

Ashley-Koch A, Yang Q, Olney RS.

Am J Epidemiol. 2000 May 1;151(9):839-45. Review.

PMID:
10791557
6.

[Neonatal screening for sickle-cell disease].

Wierenga KJ.

Ned Tijdschr Geneeskd. 1997 Jan 25;141(4):184-7. Dutch.

PMID:
9064525
7.

Advances in the treatment of sickle cell disease in children.

Scott RB.

Am J Dis Child. 1985 Dec;139(12):1219-22.

PMID:
3904408
8.

Is a national program to prevent sickle cell disease possible?

Bowman JE.

Am J Pediatr Hematol Oncol. 1983 Winter;5(4):367-72.

PMID:
6367521
9.

Mortality among children with sickle cell disease identified by newborn screening during 1990-1994--California, Illinois, and New York.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 1998 Mar 13;47(9):169-72.

10.

Update: newborn screening for sickle cell disease--California, Illinois, and New York, 1998.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2000 Aug 18;49(32):729-31.

11.

[Sickle cell disease in the neonatal period].

de Montalembert M.

J Gynecol Obstet Biol Reprod (Paris). 2004 Feb;33(1 Suppl):S12-4. Review. French.

12.

A primary care provider's guide to preventive and acute care management of adults and children with sickle cell disease.

Pack-Mabien A, Haynes J Jr.

J Am Acad Nurse Pract. 2009 May;21(5):250-7. doi: 10.1111/j.1745-7599.2009.00401.x. Review.

PMID:
19432908
13.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology..

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
14.

Examination of the communication practices between state newborn screening programs and the medical home.

Kim S, Lloyd-Puryear MA, Tonniges TF.

Pediatrics. 2003 Feb;111(2):E120-6.

PMID:
12563084
15.

Genetic Blood Disorders Survey in the Sultanate of Oman.

Al-Riyami A, Ebrahim GJ.

J Trop Pediatr. 2003 Jul;49 Suppl 1:i1-20.

PMID:
12934793
16.

Dental screening and referral of young children by pediatric primary care providers.

dela Cruz GG, Rozier RG, Slade G.

Pediatrics. 2004 Nov;114(5):e642-52.

PMID:
15520094
17.

Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.

Tshilolo L, Kafando E, Sawadogo M, Cotton F, Vertongen F, Ferster A, Gulbis B.

Public Health. 2008 Sep;122(9):933-41. doi: 10.1016/j.puhe.2007.12.005. Epub 2008 Jun 16. Review.

PMID:
18555498
18.

Newborn screening for sickle cell disease: effect on mortality.

Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B.

Pediatrics. 1988 Jun;81(6):749-55.

PMID:
3368274
19.

From concept to application: the impact of a community-wide intervention to improve the delivery of preventive services to children.

Margolis PA, Stevens R, Bordley WC, Stuart J, Harlan C, Keyes-Elstein L, Wisseh S.

Pediatrics. 2001 Sep;108(3):E42.

PMID:
11533360
20.

Health supervision for children with sickle cell disease.

Section on Hematology/Oncology Committee on Genetics.; American Academy of Pediatrics..

Pediatrics. 2002 Mar;109(3):526-35.

PMID:
11875155

Supplemental Content

Support Center